Pharma Report with Clinical Professionals – Digital Spotlight

Pharma Report with Clinical Professionals – Digital Spotlight

– When comparing the monthly average of digital vacancies in 2020 so far we can see activity is up 11% on last year
– An increasing proportion of the marketing vacancies in pharmaceuticals companies are for digital roles. This trend has been a gradual one over time, but for example, when we compare Q1 2018, we see 9.4% of marketing roles were digital, whereas by Q2 2020, this had risen to 13.7%.
– We see a surge in activity in Poland specifically in 2020 with three times as many vacancies this year, compared to last.

COVID-19 and the implications for the UK Labour Market

COVID-19 and the implications for the UK Labour Market

When analysing activity in the Real Estate industry, the contrast between London & the South East, and
the rest of the country becomes self-evident. The impact of Brexit has been much spoken about, equally
with house prices specifically, the fall in London is clear, and can be attributed, were across the South,
whilst the drop is …

Life Sciences Report June 2020 – Clinical

Life Sciences Report June 2020 – Clinical

While the Pharmaceutical industry has proven to be more resilient against the impact of the COVID-19 crisis than others, it has not been immune. Indeed, the most immediate impact seems to have been on …

Life Sciences Report May 2020 – Procurement

Life Sciences Report May 2020 – Procurement

For the pharmaceuticals industry, whilst the impact of the Covid19 crisis has yet to be seen, already questions are being asked about whether it makes sense to have outsourced manufacturing of medicines, as supply chains come under threat through …

Life Sciences Report April 2020 – Quality Assurance

Life Sciences Report April 2020 – Quality Assurance

As the Covid19 crisis hits, QA will have an increasingly important part to play under the spotlight, as Governments pressure Pharmaceuticals companies to produce a scalable cure. Already the sector had seen continuous …

Life Sciences Report March 2020 – Drug Safety

Life Sciences Report March 2020 – Drug Safety

Pharmaceuticals companies, 2020 face their own unique challenges. Already there are multiple blockbuster drugs due to expire this year, including Lucentis produced by Roche & Novartis, along with Spyrcel. Now with the advent of the Coronavirus crisis, companies will be under …